这是一篇来自已证抗体库的有关
人类 IRF7的综述,是根据11篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合IRF7 抗体。
IRF7 同义词: IMD39; IRF-7; IRF-7H; IRF7A; IRF7B; IRF7C; IRF7H
圣克鲁斯生物技术
小鼠 单克隆(G-8) | | 圣克鲁斯生物技术 IRF7抗体(Santa, sc-74472)被用于被用于免疫印迹在人类样本上 (图 3c). Sci Adv (2019) ncbi |
小鼠 单克隆(G-8) | | 圣克鲁斯生物技术 IRF7抗体(Santa Cruz, sc-74472)被用于被用于染色质免疫沉淀
在人类样本上 (图 8b). J Exp Med (2016) ncbi |
小鼠 单克隆(F-1) | | 圣克鲁斯生物技术 IRF7抗体(Santa Cruz, sc-74471)被用于被用于EMSA在小鼠样本上 (图 4a). Sci Transl Med (2016) ncbi |
BioLegend
小鼠 单克隆(12G9A36) | | BioLegend IRF7抗体(BioLegend, 656008)被用于被用于流式细胞仪在人类样本上 (图 2d). J Clin Invest (2017) ncbi |
赛信通(上海)生物试剂有限公司
domestic rabbit 多克隆 | | 赛信通(上海)生物试剂有限公司 IRF7抗体(CST, 4920)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3e). J Biol Chem (2021) ncbi |
domestic rabbit 多克隆 | | 赛信通(上海)生物试剂有限公司 IRF7抗体(CST, 5184)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3e). J Biol Chem (2021) ncbi |
domestic rabbit 多克隆 | | 赛信通(上海)生物试剂有限公司 IRF7抗体(Cell Signaling Technology, 4920)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3c). JCI Insight (2020) ncbi |
domestic rabbit 多克隆 | - 免疫印迹基因敲除验证; 人类; 图 3a
- 免疫印迹; 人类; 图 3a
| 赛信通(上海)生物试剂有限公司 IRF7抗体(Cell Signaling, 4920)被用于被用于免疫印迹基因敲除验证在人类样本上 (图 3a) 和 被用于免疫印迹在人类样本上 (图 3a). MBio (2019) ncbi |
domestic rabbit 单克隆(D2A1J) | | 赛信通(上海)生物试剂有限公司 IRF7抗体(CST, D2A1J)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5b). Front Immunol (2018) ncbi |
domestic rabbit 多克隆 | | 赛信通(上海)生物试剂有限公司 IRF7抗体(Cell Signaling Technology, 4920)被用于被用于免疫印迹在人类样本上 (图 3e). J Clin Invest (2018) ncbi |
domestic rabbit 多克隆 | | 赛信通(上海)生物试剂有限公司 IRF7抗体(Cell Signaling Technology, 5184)被用于被用于免疫印迹在人类样本上 (图 s4h). Nat Med (2018) ncbi |
碧迪BD
小鼠 单克隆(K40-321) | | 碧迪BD IRF7抗体(Becton Dickenson, K40-321)被用于被用于流式细胞仪在人类样本上浓度为1:50. PLoS ONE (2014) ncbi |
Kulkarni N, O Neill A, Dokoshi T, Luo E, Wong G, Gallo R. Sequence determinants in the cathelicidin LL-37 that promote inflammation via presentation of RNA to scavenger receptors. J Biol Chem. 2021;297:100828
pubmed 出版商
de Cubas A, Dunker W, Zaninovich A, Hongo R, Bhatia A, Panda A,
et al. DNA hypomethylation promotes transposable element expression and activation of immune signaling in renal cell cancer. JCI Insight. 2020;5:
pubmed 出版商
Maarifi G, Smith N, Maillet S, Moncorgé O, Chamontin C, Edouard J,
et al. TRIM8 is required for virus-induced IFN response in human plasmacytoid dendritic cells. Sci Adv. 2019;5:eaax3511
pubmed 出版商
Botto S, Abraham J, Mizuno N, Pryke K, Gall B, Landais I,
et al. Human Cytomegalovirus Immediate Early 86-kDa Protein Blocks Transcription and Induces Degradation of the Immature Interleukin-1β Protein during Virion-Mediated Activation of the AIM2 Inflammasome. MBio. 2019;10:
pubmed 出版商
Alam M, Yang D, Trivett A, Meyer T, Oppenheim J. HMGN1 and R848 Synergistically Activate Dendritic Cells Using Multiple Signaling Pathways. Front Immunol. 2018;9:2982
pubmed 出版商
Bi E, Li R, Bover L, Li H, Su P, Ma X,
et al. E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs. J Clin Invest. 2018;128:4821-4831
pubmed 出版商
Mathew N, Baumgartner F, Braun L, O Sullivan D, Thomas S, Waterhouse M,
et al. Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. Nat Med. 2018;24:282-291
pubmed 出版商
Veenhuis R, Freeman Z, Korleski J, Cohen L, Massaccesi G, Tomasi A,
et al. HIV-antibody complexes enhance production of type I interferon by plasmacytoid dendritic cells. J Clin Invest. 2017;127:4352-4364
pubmed 出版商
Bao M, Wang Y, Liu Y, Shi P, Lu H, Sha W,
et al. NFATC3 promotes IRF7 transcriptional activity in plasmacy--toid dendritic cells. J Exp Med. 2016;213:2383-2398
pubmed
Puthia M, Ambite I, Cafaro C, Butler D, Huang Y, Lutay N,
et al. IRF7 inhibition prevents destructive innate immunity-A target for nonantibiotic therapy of bacterial infections. Sci Transl Med. 2016;8:336ra59
pubmed 出版商
Pritchard A, White O, Burel J, Carroll M, Phipps S, Upham J. Asthma is associated with multiple alterations in anti-viral innate signalling pathways. PLoS ONE. 2014;9:e106501
pubmed 出版商